Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

Marina Shestakova; Boris Kvasnikov; Ekaterina Erina; Elena Isachenko; Alexander Andreev

doi:10.1136/bmjdrc-2022-003290

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

PDF +
Supplementary
Material

Cardiovascular and metabolic risk

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

Online download statistics by month:

Online download statistics by month: July 2023 to August 2024

	Abstract	Full	Pdf
Jul 2023	430	430	146
Aug 2023	277	281	59
Sep 2023	261	265	50
Oct 2023	285	288	23
Nov 2023	254	260	31
Dec 2023	189	189	51
Jan 2024	67	67	28
Feb 2024	65	62	22
Mar 2024	89	87	33
Apr 2024	90	90	45
May 2024	79	75	21
Jun 2024	80	73	32
Jul 2024	102	95	31
Aug 2024	55	52	23
Total	2323	2314	595

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: July 2023 to August 2024

Read the full text or download the PDF:

Log in using your username and password